MetaCap

Who Owns Mesoblast Stock?

NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.89-0.29 (-2.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
3.38%
Institutional holders
96
  • Institutions 3.4%
  • Insiders 57.3%
  • Public and other 39.3%

Who owns Mesoblast stock?

Institutional investors own about 3.4% of Mesoblast's shares, spread across 96 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 57.34% of MESO.

The largest institutional holders are Morgan Stanley (0.55%), Blackrock Inc. (0.51%) and Susquehanna International Group, LLP (0.35%). Together, the top 10 institutions control 2.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MESO positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of MESO

Mesoblast top institutional holders
InstitutionShares% HeldChange
Morgan Stanley718.61K0.55%+39.7%
Blackrock Inc.664.28K0.51%+5.3%
Susquehanna International Group, LLP457.74K0.35%+18.4%
Goldman Sachs Group Inc395.61K0.30%-0.4%
BNP Paribas Asset Management Holding S.A.259.70K0.20%+100.0%
UBS Group AG197.18K0.15%-1.4%
Arax Advisory Partners175.32K0.13%+4.3%
Group One Trading, LLC132.24K0.10%+200.3%
Bank of America Corporation100.00K0.08%0.0%
Penbrook Management LLC87.08K0.07%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of MESO

Mesoblast top fund holders
FundShares% Held
iShares Trust-iShares Biotechnology ETF573.61K0.44%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund34.22K0.03%
Trust for Professional Managers-ActivePassive International Equity ETF8.84K0.01%
Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF7.16K0.01%
Steward Funds Inc-Steward Values Enhanced International Fund6.51K0.01%
Invesco Exchange-Traded Fund Trust II-Invesco Nasdaq Biotechnology ETF3.27K0.00%
ProShares Trust-ProShares Ultra Nasdaq Biotechnology2.09K0.00%

Frequently asked questions

Who is the largest shareholder of Mesoblast?

Morgan Stanley is the largest institutional shareholder of MESO, owning 0.55% of shares outstanding (718.61K shares) as of its latest 13F filing.

What percentage of Mesoblast is owned by institutions?

Institutions own about 3.4% of MESO shares and 7.9% of the public float.

How much of Mesoblast do insiders own?

Insiders, such as officers and directors, own about 57.34% of MESO shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related